A month has gone by since the last earnings report for Medifast (MED). Shares have lost about 5.8% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...

With its stock down 15% over the past week, it is easy to disregard Medifast (NYSE:MED). It is possible that the markets have ignored the company's differing financials and decided to lean-in to ...

Get Our Latest Stock Analysis on MED Medifast Price Performance Shares of NYSE:MED opened at $19.44 on Thursday. The company has a quick ratio of 2.55, a current ratio of 3.11 and a debt-to-equity ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

2021; Wilding et al., 2021). Medifast embraces this holistic strategy and leverages this data in its unique approach. The company offers personalized plans that incorporate both the use of ...

With its stock down 15% over the past week, it is easy to disregard Medifast (NYSE:MED). It is possible that the markets have ignored the company's differing financials and decided to lean-in to the ...

Medifast, Inc. MED is currently trading at a forward 12-month price-to-earnings (P/E) ratio of 17.60, higher than the industry average of 15.39. This inflated valuation suggests that the market is ...

Investors in Medifast, Inc. MED need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 20, 2024 $42.50 Call had some of the highest implied ...